# GLP-1/Basal Insulin Combination Therapy

> **NCT02895672** · — · COMPLETED · sponsor: **Albany College of Pharmacy and Health Sciences** · enrollment: 150 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** GLP-1 therapy

## Key facts

- **NCT ID:** NCT02895672
- **Lead sponsor:** Albany College of Pharmacy and Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2016-11
- **Final completion:** 2016-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02895672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02895672, "GLP-1/Basal Insulin Combination Therapy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02895672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*